Related Experiment Video
Updated: Aug 14, 2025

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Serum cytokine profiling reveals different immune response patterns during general and severe Mycoplasma pneumoniae
Zhikun Zhang1, Haiwei Dou1, Peng Tu1
1Beijing Tropical Medicine Research Institute, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Abstract:
Mycoplasma pneumoniae (MP) is an important human pathogen that mainly affects children causing general and severe Mycoplasma pneumoniae pneumonia (G/SMPP). In the present study, a comprehensive immune response data (33 cytokines) was obtained in school-age children (3-9 years old) during MPP, aiming to analyze the immune response patterns during MPP. At acute phase, changes of cytokines were both detected in GMPP (24/33) and SMPP (23/33) groups compared to the healthy group (p < 0.05), with 20 identical cytokines. Between MPP groups, the levels of 13 cytokines (IL-2, IL-10, IL-11, IL-12, IL-20, IL-28A, IL-32, IL-35, IFN-α2, IFN-γ, IFN-β, BAFF, and TSLP) were higher and three cytokines (LIGHT, OPN and CHI3L1) were lower in the SMPP group than in the GMPP group (p < 0.05). Function analysis reveals that macrophage function (sCD163, CHI3L1) are not activated in both MPP groups; difference in regulatory patterns of T cells (IL26, IL27, OPN, LIGHT) and defective activation of B cells (BAFF) were detected in the SMPP group compared to the GMPP group. Besides, the level of osteocalcin; sIL-6Rβ and MMP-2 are both decreased in MPP groups at acute and convalescent phases compared to the healthy group, among which the levels of sIL-6Rβ and MMP-2 showed negative correlations (p < 0.1) to the application of bronchial lavage in SMPP group, indicating their roles in the development of MPP. At the convalescent phase, more cytokines recovered in GMPP (18) than SMPP (11), revealing better controlled immune response during GMPP. These results reveal different immune response patterns during GMPP and SMPP. In addition, the differentiated cytokines may serve as potential indicators of SMPP; early intervention on immune response regulations may be helpful in reducing the severity of SMPP.
Insights
This study reveals distinct immune responses in children with general and severe Mycoplasma pneumoniae pneumonia (MPP). Severe cases show unique cytokine profiles, suggesting potential biomarkers and targets for early intervention in pediatric pneumonia.
Area of Science:
- Immunology
- Pediatric Infectious Diseases
- Respiratory Medicine
Background:
- Mycoplasma pneumoniae (MP) is a significant pathogen causing pneumonia in children.
- Understanding the immune response in general (GMPP) versus severe (SMPP) pediatric MP pneumonia is crucial for effective treatment.
- Cytokine profiles offer insights into disease pathogenesis and severity.
Purpose of the Study:
- To comprehensively analyze and compare immune response patterns, specifically cytokine profiles, in children with GMPP and SMPP.
- To identify potential immune markers differentiating disease severity.
- To explore therapeutic implications for immune response modulation in SMPP.
Main Methods:
- Measurement of 33 cytokines in school-aged children (3-9 years) during acute and convalescent phases of MPP.
- Comparison of cytokine levels between GMPP, SMPP, and healthy control groups.
- Functional analysis of immune cell activation (macrophages, T cells, B cells) and correlation studies.
Main Results:
- Significant cytokine level changes were observed in both GMPP and SMPP groups compared to healthy controls.
- SMPP group exhibited distinct cytokine profiles, with higher levels of certain cytokines (e.g., IL-2, IFN-γ, BAFF) and lower levels of others (e.g., LIGHT, OPN) compared to GMPP.
- Impaired T-cell regulation and B-cell activation were noted in SMPP; cytokine recovery was slower in SMPP than GMPP.
Conclusions:
- Distinct immune response patterns characterize GMPP and SMPP in children.
- Specific differentiated cytokines may serve as potential biomarkers for identifying severe pediatric MP pneumonia.
- Targeted immune modulation strategies could be beneficial for reducing SMPP severity.
More Related Videos
04:32Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013